MEDS - Earnings announcements

TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ:MEDS) ("TRxADE"), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file its Quarterly Report on Form 10-Q for Q2 pursuant to a Form 12b-25 filed with the SEC. The Company is not able to timely file its 10-Q by August 14, 2023, the original due date for such filing, without unreasonable effort or expense, because additional time is required to finalize its financial statements and related disclosures required to be included in the 10-Q in connection with the recent merger transaction it completed in July. TRxADE will release financial results for the second quarter 202

TAMPA, FL / ACCESSWIRE / July 31, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the second quarter 2023, after market close on August 14, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, August 14th, 2023, at 6:00 p.m. Eastern time to discuss TRxADE HEALTH's second quarter 2023 financial results. The call will conclud

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the quarter ended March 31, 2023. 2023 and Subsequent Operational Highlights TRxADE continued to expand the TRxADE drug procurement marketplace nationwide, increasing new members approximately 1,100 for the first quarter of 2023 compared to the first quarter of 2022, bringing the t

TAMPA, FL / ACCESSWIRE / May 5, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2023, after market close on May 15, 2023. Please note that this is a revised date from the original reporting date of May 8, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, May 15, 2023, at 6:00 p.m. Eastern time to discus

TAMPA, FL / ACCESSWIRE / April 25, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the first quarter 2023, after market close on May 8, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, May 8, 2023, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's first quarter 2023 financial results. The call will conclude with a Q&

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / March 27, 2023 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the year ended December 31, 2022.2022 and Subsequent Operational HighlightsTRxADE continued to expand the TRxADE drug procurement marketplace nationwide, adding 1,212 new registered members during fiscal 2022, bringing the total registered members to approximately 14,400+ at December 31, 2

TAMPA, FL / ACCESSWIRE / March 13, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for fourth quarter and year-end 2022, after market close on March 27, 2023. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, March 27, 2023, at 5:30 p.m. Eastern time to discuss TRxADE HEALTH's fourth quarter and year-end 2022 financial results. Th

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, Nov. 07, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the 2022 third quarter (Q3) ended September 30, 2022. Third Quarter 2022 and Subsequent Operational Highlights TRxADE continued to expand the TRxADE drug procurement marketplace nationwide, adding 291 new registered members in Q3 2022 and 1,149 new r

TAMPA, FL / ACCESSWIRE / October 24, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for third quarter 2022, after market close on November 7, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, November 7, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's third quarter 2022 financial results. The call will conclude w

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / July 25, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the 2022 second quarter (Q2) ended June 30, 2022.Second Quarter 2022 and Subsequent Operational HighlightsTRxADE continued to expand the TRxADE drug procurement marketplace nationwide, adding 319 new registered members in Q2 2022 and 685 new registered members during the first six months of

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / May 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the 2022 first quarter (Q1) ended March 31, 2022.First Quarter 2022 and Subsequent Operational HighlightsTRxADE continued to expand the TRxADE drug procurement marketplace nationwide, adding 339 new registered members in Q1 2022, bringing the total registered members to approximately 13,475+ a

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for first quarter 2022, after market close on May 9, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, May 9, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's first quarter 2022 financial results. The call will conclude with a Q&A fr

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / March 28, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE", "TRxADE HEALTH" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the fourth quarter (Q4) and year ended (FY) December 31, 2021.Fourth Quarter 2021 Financial Summary and Operational HighlightsTRxADE continued to expand the TRxADE drug procurement marketplace nationwide, adding 175 new registered members in Q4 2021, bringing the total regi

TAMPA, FL / ACCESSWIRE / March 14, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the fourth quarter and Year End 2021, after market close on March 28, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.In addition, management will host a conference call on Monday, March 28, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's fourth quarter and year end 2021 financial results

Third Quarter 2021 Revenue Increased 34.3% over Second Quarter 2021TAMPA, FL / ACCESSWIRE / October 25, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the third quarter ended September 30, 2021.Recent Operational Highlights:TRxADE HEALTH continued to expand its drug procurement marketplace nationwide, adding approximately 250 new registered members in the third quarter, bringing the total registered members to over 12,950.Bonum Health, a TRxADE Company, launched pre-paid digital te

TAMPA, FL / ACCESSWIRE / October 11, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the third quarter of 2021, after market close on October 25, 2021.Management will host a conference call on Monday, October 25, 2021 at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's third quarter 2021 financial results. The call will conclude with Q&A from participants.To participate, please use the following information:Q3 2021 Conference Call and WebcastDate: Monday, October 25, 2021Time: 5:00 p.m. E

Q2 2021 Gross Profit Margin Expands Significantly to 44.3%TAMPA, FL / ACCESSWIRE / July 26, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the second quarter ended June 30, 2021.Recent Operational Highlights:Trxade continued to expand the Trxade drug procurement marketplace nationwide, adding approximately 195 new registered members in Q2 2021, bringing the total registered members to 12,700+.Signed enterprise retail partnerships with Winn-Dixie, Big Y, SpartanNash and Brookshire G

First Quarter Revenues Increased 39% to $3.1 Million TAMPA, FL, April 26, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the first quarter ended March 31, 2021. Selected Financial Highlights $ in millions Q12021 Q12020 % Increase (Decrease)Revenues $3.1 $2.2 39%Gross Profit $1.4 $1.6 (16%)Gross Profit Percentage 45% 74% (39%)Net Income (Loss) ($0.7) $0.2 (446%)Adjusted EBITDA1 ($0.5) $0.3 (244%) 1 Adjusted EBITDA is a non-GAAP financial measure and is

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, March 29, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced its financial results for the fourth quarter (Q4) and year ended (FY) December 31, 2020. Selected Financial Highlights $ in MillionsQ4% Increase (Decrease)FY% Increase (Decrease)2020 2019 2020 2019 Revenues$2.0 $1.7 17.1%$17.1 $7.4 130.3%Gross Profit$0.1 $1.3 (90.0%)$5.7 $4.9 17.2%Gross Margin Percentage6.5%76.5